Gastroenterology 1
Gastroenterology 2
Gastroenterology 3
Gastroenterology 4
Gastroenterology 5
100

Pharmacologic prophylaxis for encephalopathy for those at risk after hepatic shunt placement

Rifaximin (accept Xifaxan; also accept no prophylaxis)

100

The most common cause of lymphocytic gastritis

Celiac disease (accept celiac sprue, nontropical sprue, endemic sprue, gluten enteropathy)

100

Liver condition most commonly associated with anti-smooth muscle antibody

Type 1 autoimmune hepatitis (accept autoimmune hepatitis)

100

First step in managing uncomplicated GERD

Empiric PPI

100

Preferred celiac disease screening test

Anti–tissue transglutaminase IgA antibody

200

Bacteria, eradication of which is key to the treatment of MALT lymphoma

Helicobacter pylori (accept H. pylori)

200

Most commonly used serum marker for hepatocellular carcinoma

Alpha-fetoprotein (accept AFP)

200

Diabetes medication class shown to improve nonalcoholic steatohepatitis (NASH) irrespective of weight loss

Glucagon-like peptide-1 (GLP-1) agonists (Accept incretin mimetics. Do not accept GLP-1 without agonist.)

200

Empiric therapy for functional dyspepsia

PPI

200

Gold standard celiac disease diagnostic test

Duodenal biopsy

300

Most common infectious cause of type II mixed cryoglobulinemia

Hepatitis C

300

Initial medical therapy for primary biliary cholangitis

Ursodeoxycholic acid (accept UDCA, ursodiol)

300

FDA-approved antibiotic for the treatment of IBS with predominant diarrhea

Rifaximin (accept Xifaxan)

300

Gold standard diagnostic test for achalasia

Esophageal manometry

300

Serologic test for celiac disease in IgA deficiency

Anti–deamidated gliadin peptide IgG antibodies or tissue transglutaminase IgG antibodies

400

Organ serving as a reservoir for chronic Salmonella typhi infection

Gallbladder

400

Superior-most arterial branch off the aorta associated with chronic mesenteric ischemia

Celiac artery (accept celiac trunk)

400

Subcutaneous opioid antagonist approved for opioid-induced constipation

Methylnaltrexone (accept Relistor)

400

Endoscopic findings in eosinophilic esophagitis

Rings and furrows, luminal narrowing, edema, exudates

400

High-risk findings for PUD rebleeding

Active bleeding, nonbleeding visible vessels, adherent clots

500

Eponymous triad of hemolytic anemia, jaundice, and hypertriglyceridemia with heavy alcohol use

Zieve syndrome

500

Eponymous stratification tool that identifies upper GI bleeding patients who are “low risk” and candidates for outpatient management

Glasgow-Blatchford score (accept Blatchford score or Rockall score)

500

Vesicular rash in celiac disease caused by granular deposition of IgA

Dermatitis herpetiformis

500

Supporting test for GERD extraesophageal manifestations

Ambulatory pH monitoring off acid-suppressive therapy

500

ARB associated with celiac-like enteropathy

Olmesartan